Anitha Shenoy, PhD, MS

Assistant Dean of Student Affairs and Enrollment
Associate Professor


PhD in Molecular Cell Biology, College of Medicine, University of Florida, Gainesville, Florida
MSc in Medical Biochemistry, Kasturba Medical College Manipal University, Manipal, India


Pharmacology, Biochemistry, Physiology, Molecular Cell Biology, Oncology

Most recent teaching and experience:

Associate Professor and Assistant Dean of Student Affairs in College of Pharmacy, CHSU
Lecturer in the Department of Biochemistry, Sri Devraj Urs Medical College, Kolar, India
Clinical Biochemist, R. L. Jallappa Hospital and Research Centre, Kolar, India


Molecular Biology and Cancer Biology

Most recent publications and presentations:

Shenoy AK, Pi L, Ligocki AP, Hosaka K, Cogle CR, Scott EW. argeting Redundant ROBO1 and SDF-1 Pathways Prevents Adult Hemangioblast Derived-EPC and CEC Activity Effectively Blocking Tumor Neovascularization. Stem Cell Rev Rep. 2023 May;19(4):928-941. doi: 10.1007/s12015-022-10498-7. Impact Factor: 4.79

Liang M, Li JW, Luo H, Lulu S, Calbay O, Shenoy A, Tan M, Law BK, Huang S, Xiao TS, Chen H, Wu L, Chang J, Lu J. Epithelial-Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy Stress. Cells. 2022 Jul 15;11(14):2208. doi: 10.3390/cells11142208. Impact Factor: 7.66

Neiheisel A, Kaur M, Ma N, Havard P, Shenoy AK. Wnt Pathway Modulators in Cancer Therapeutics– An Update on Completed and Ongoing Clinical Trials. Int J Cancer. 2021 Sep 18. doi: 10.1002/ijc.33811. Epub ahead of print. Impact Factor: 7.39

Chen C, Shenoy AK, Padia R, Fang D, Jing Q, Yang P, Su SB, Huang S. Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2′, 4′-Tetrahydroxychalcone. J Exp Clin Cancer Res. 2018 Oct 3;37(1):243. doi: 10.1186/s13046-018-0902-4. Impact Factor: 11.16

Patra A, Satpathy S, Shenoy AK, Bush JA, Kazi M, Hussain MD. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug-resistant cancers. Int J Nanomedicine. 2018 May 16; 13:2869-2881. doi: 10.2147/IJN.S153094. eCollection 2018. Impact Factor: 3.06

Lu J, Shenoy AK. Epithelial-to-Pericyte transition in cancer. Cancers (Basel). 2017; 9 (7) pii: E77. DOI: 10.3390/cancers9070077. Impact Factor: 6.63

Shenoy AK, Lu J. Relevance of epithelial-to-pericyte transition in cancer. Molecular and Cellular Oncology. 2016 DOI: 10.1080/23723556.2016.1260672 Impact Factor: 1.24

Shenoy AK, Jin Y, Luo H, Tang M, Pampo C, Shao R, Siemann DW, Wu L, Heldermon CD, Law BK, Chang LJ, Lu J. Epithelial-to-Mesenchymal transition confers pericyte properties on cancer cells. Journal of Clinical Investigation. 2016; 126 (11): 4174-4186 Impact Factor: 14.80

Shenoy AK, Lu J. Cancer cells remodel themselves and vasculature to overcome the endothelial barrier. Cancer Lett. 2016; 380 (2): 534-44 Impact Factor: 7.85